Examkin

Question

Difficulty: Very hardOrdering Laboratory Tests

Evaluation in the outpatient endocrinology clinic is requested for a 31-year-old female due to markedly abnormal thyroid function tests. The patient originally consulted her primary care provider for generalized hair thinning, for which she recently started an over-the-counter hair, skin, and nail megavitamin complex. She currently reports feeling entirely well, specifically denying any palpitations, heat intolerance, unintentional weight changes, anxiety, or tremulousness. Vital signs are temperature 37.0°C (98.6°F), blood pressure 114/72 mm Hg, and pulse 68/min and regular. Physical examination reveals a normal-sized, non-nodular thyroid gland without palpable thrill or audible bruit. There is no evidence of proptosis, lid lag, or pretibial myxedema. Her peripheral reflexes are 2+ and symmetric bilaterally without delay in the relaxation phase.

Recent laboratory studies obtained by her primary provider demonstrate:

Laboratory TestPatient ResultReference Range
Thyroid-stimulating hormone (TSH)0.02 µU/mL0.5–5.0 µU/mL
Free thyroxine (FT4)3.8 ng/dL0.8–1.8 ng/dL

Which of the following is the most appropriate next step in laboratory evaluation?

  1. A
    Serum thyrotropin receptor antibody quantification
  2. B
    Serum total triiodothyronine measurement
  3. C
    24-hour urinary iodine excretion test
  4. Repeat serum TSH and free T4 assays 3 to 5 days after discontinuation of the megavitamin complexAnswer
  5. E
    Serum thyroxine-binding globulin level

Answer

The most appropriate next step is to repeat the serum TSH and free T4 assays 3 to 5 days after discontinuing the megavitamin complex.
The correct next step is to repeat the thyroid function tests after discontinuing the megavitamin complex. This patient's presentation is characterized by a striking discordance: she has laboratory evidence of severe primary hyperthyroidism (suppressed TSH, elevated FT4) but is completely asymptomatic with normal vital signs. This discrepancy highly suggests a laboratory artifact. The patient recently started a hair, skin, and nail megavitamin, which frequently contains high doses of biotin (Vitamin B7). Many automated thyroid immunoassays rely on streptavidin-biotin binding. High serum concentrations of exogenous biotin displace the assay reagents. In competitive assays (typically used for FT4), this interference causes a falsely elevated result. In sandwich assays (typically used for TSH), it causes a falsely suppressed result. Together, this perfectly mimics primary hyperthyroidism. The standard of care is to instruct the patient to stop the biotin-containing supplement for at least 3 to 5 days to allow for renal clearance, followed by a repeat measurement of TSH and FT4 to confirm the artifact before ordering etiologic workups.

Step-by-Step Solution

1
Analyze the clinical presentation and physical exam findings.
The patient is completely asymptomatic with normal vital signs, a normal thyroid exam, and no clinical signs of thyrotoxicosis.
To establish the pre-test probability of actual clinical thyroid disease.
2
Interpret the laboratory findings.
Labs show a suppressed TSH and an elevated FT4, a pattern that typically indicates primary hyperthyroidism.
To compare the biochemical data against the patient's clinical picture.
3
Identify the discordance and evaluate potential confounders from the patient's history.
There is a striking discrepancy between the severe lab abnormalities and the lack of symptoms. The history of starting an over-the-counter hair, skin, and nail megavitamin suggests high-dose biotin (Vitamin B7) intake.
To identify causes of isolated laboratory artifacts when clinical correlation is absent.
4
Determine the appropriate diagnostic sequence to rule out assay interference.
The best action is to withhold the suspect supplement to allow for clearance, then retest the thyroid function panel, rather than pursuing etiologic testing for hyperthyroidism.
Biotin interferes with streptavidin-biotin immunoassays, mimicking Graves' disease by causing falsely low TSH and falsely high FT4. Removing the interference confirms the artifact.

Key Concept

High-dose exogenous biotin interferes with streptavidin-biotin immunoassays, producing a falsely suppressed TSH and falsely elevated free T4 that mimics primary hyperthyroidism. A striking discordance between severe biochemical abnormalities and an asymptomatic clinical presentation should prompt repeating the tests after a biotin washout period.
Estimated Time:1m 30s
Rate this question

Topics

Ordering Laboratory Tests

More questions from this topic